Gene therapy: More than half of industry revenue is generated by sales of healthcare products
Biotechnology in the US The Biotechnology industry is growing quickly, characterized by a multitude of product applications and a wide range of burgeoning markets. Growing demand for ethanol indicates the increasing importance of crop yields to agricultural customers, which have consistently demanded industry products over the past five years and will likely continue to do so over the five years to 2024. Similarly, more than half industry revenue is generated by sales of healthcare products, and the aging US population has driven demand for that segment’s products as a result of their growing medical needs. However, expired patents have created the opportunity for new entrants to develop new drugs with the possibility of being purchased by larger companies during the latter part of the period. Meanwhile, as competition from overseas falls over the next five years, industry revenue is projected to grow.
Companies in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Our reports have been used by over 10K customers, including:
129 pages •
By Asia Market Information & Development Company
• Mar 2021
This study focuses on China’s Biotechnology Equipment industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...
The sterility testing market is expected to reach USD 941.0 million by 2021 from USD 528.0 million in 2016, at a CAGR of 12.3%. The major drivers for the market include growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research. Over the years,...
Biotechnology Patents Registrations
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.